aripiprazole patent

Otsuka vs. Sun Pharma reshapes Australian patent term extension rules for pharmaceutical formulations. The Full Court limits PTE to active ingredients per se, leaving controlled‑release aripiprazole depot products outside the extension regime and impacting lifecycle strategies.